Form 4: Ellen O'Connor Vos Acquires Options in Modular Medical, Inc.

Director Ellen O'Connor Vos reports acquisition of options to purchase 7,500 shares of Modular Medical, Inc. common stock.

Summary

• On June 30, 2024, Ellen O'Connor Vos, a director of Modular Medical, Inc. (MODD), acquired options to purchase 7,500 shares of common stock.
• The options were granted under the Issuer's Outside Director Compensation Plan.
• The exercise price of the options is $1.56 per share.
• The options were fully vested and exercisable on the grant date, June 30, 2024, and expire on June 30, 2034.
• Following the transaction, Vos beneficially owns options to purchase 7,500 shares of Modular Medical, Inc. common stock.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The sentiment is neutral as it simply reports a transaction related to director compensation.

Positives

• The grant of options to a director aligns their interests with those of the shareholders.
• The options were granted under the Issuer's Outside Director Compensation Plan.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This is a standard Form 4 filing related to director compensation, a common practice in publicly traded companies to incentivize and align the interests of directors with shareholders.

Comparison to Industry Standards

• Director compensation packages often include stock options to align director and shareholder interests.
• The vesting schedule and exercise price are typical components of such option grants.
• The specific terms of the option grant (e.g., number of shares, exercise price, vesting schedule) would need to be compared to those of peer companies to assess its competitiveness.

Stakeholder Impact

• The grant of options to a director can potentially align their interests with those of shareholders, encouraging decisions that increase shareholder value.

Key Dates